personal photo of Wesley Richerson, PhD

Wesley Richerson, PhD

Tagline:Post-Doctoral Research Fellow in the VUMC Department of Neurology

Nashville, TN, USA

About Me

I started as a post-doctoral fellow in the Neurology department in Fall of 2022 after completing his PhD in the joint Medical College of Wisconsin/Marquette University Biomedical Engineering Department, using MRI to better understand hemodialysis-related neurodegeneration. He is interested in developing and using quantitative cerebrovascular MRI techniques to understand pathophysiology and disease progression to help clinicians make better informed decisions on treatments and interventions. Currently, I am working primarily on sickle cell anemia and moyamoya disease projects. In his free time, I am an avid cyclist and enjoy going to concerts at The Basement East, movies at the Belcourt theater, and playing pickup basketball.

Education

  • Doctor of Philosophy

    from: 2017, until: 2022

    Field of study:Biomedical EngineeringSchool:Medical College of WisconsinLocation:Milwaukee, WI

  • Bachelor's of Science

    from: 2013, until: 2017

    Field of study:Biomedical EngineeringSchool:Marquette UniversityLocation:Milwaukee, WI

Research Interests

  • Cerebrovascular Disease
  • Quantitative Magnetic Resonance Imaging
  • Signal Processing and Modeling
  • Cerebral Hemodynamics

Publications

  • Cerebral Blood Transit in Sickle Cell Anemia

    Journal ArticlePublisher:Journal of Magnetic Resonance ImagingDate:2026
    Authors:
    Wesley T. RichersonMegan A. AumannAlexander K. SongSamantha DavisLauren MilnerMaria GarzaDann MartinL. Taylor DavisSumit PruthiLori C. JordanManus J. Donahue
    Description:
    ABSTRACT Background Sickle cell anemia (SCA) patients upregulate cerebral blood flow to compensate for decreased arterial oxygen content. Such hyperemic conditions can manifest as venous hyperintense signal on arterial spin labeling (ASL) MRI, which may reflect faster capillary blood transit, altered oxygen extraction fraction (OEF), and infarct risk. Purpose To implement multi-delay ASL to quantify cerebral arterial arrival time (AAT), arterial transit time (ATT) to tissue, and venous arrival time (VAT) and to test whether reductions in these parameters are present in SCA and relate to condition severity. Study Type Prospective, cross-sectional. Subjects Adults with SCA (n = 40; age = 28.1 ± 7.1 years; sex = 47.5% female) and nonanemic controls (n = 24; age = 30.6 ± 6.6 years; sex = 37.5% male). Field Strength/Sequence 3 T 3D T1-weighted, 3D T2-FLuid-Attenuated-Inversion-Recovery, 2D T2-relaxation-under-spin-tagging (TRUST), 3D pseudo-Continuous ASL (pCASL) Gradient-And-Spin-Echo, and 2D multi-delay (delay range = 200–3200 ms) Pulsed ASL (PASL). Assessment Multi-delay PASL was used to quantify AAT, gray matter ATT, VAT, and labeled venous blood volume. Venous hyperintensities and OEF were quantified from 3D pCASL and TRUST, respectively. Infarcts and vasculopathy were assessed from radiological review. Statistical Tests AAT, gray matter ATT, VAT, and labeled venous blood volume were evaluated using a Wilcoxon rank-sum test; ANOVA assessed relationships with venous hyperintense signal. Continuous variable relationships were assessed using Spearman rank-correlation (significance: two-sided p < 0.05). Results Venous labeled blood volume was significantly increased in SCA (median = 0.015 mL; IQR = 0.0087–0.023 mL) versus control (median = 0.0047 mL; IQR = 0.0032–0.0092 mL) participants, whereas VAT was significantly reduced in SCA (median = 2.53 s; IQR = 2.23–2.72 s) versus control (median = 2.75 s; IQR = 2.63–2.80 s) participants. AAT, gray matter ATT, and VAT values were not significantly related to OEF (AAT: p = 0.38; gray matter ATT: p = 0.24; VAT: p = 0.48) or prior infarct (AAT: p = 0.99; gray matter ATT: p = 0.88; VAT: p = 0.98). AAT and gray matter ATT, but not VAT (p = 0.153), were directly related to hemoglobin. Conclusion SCA patients had elevated labeled venous blood volume and shorter VAT. Differential relationships between blood transit and hemoglobin across vascular compartments provides support for venous blood kinetics not representing a simple sequela of anemia severity. Evidence Level 2. Technical Stage of Development 2.
  • Cerebral blood flow in children and adults with sickle cell anemia

    Journal ArticlePublisher:NeurologyDate:2025
    Authors:
    Lori C JordanWesley RichersonMegan AumannAlexander K SongSpencer WaddleMeher R JuttukondaR Sky JonesL Taylor DavisSumit PruthiDann Martinothers
  • Cerebral hemodynamic responses to disease-modifying and curative sickle cell disease therapies

    Journal ArticlePublisher:NeurologyDate:2025
    Authors:
    Megan A AumannWesley RichersonAlexander K SongDann MartinL Taylor DavisSamantha M DavisLauren L MilnerAdetola A KassimMichael R DeBaunLori C Jordanothers
  • Detectability of white matter cerebral blood flow using arterial spin labeling MRI in patients with sickle cell disease: Relevance of flow territory, bolus arrival time and hematocrit

    Journal ArticlePublisher:Journal of Cerebral Blood Flow & MetabolismDate:2025
    Authors:
    Wesley T RichersonMegan AumannAlexander K SongJarrod J EismaSamantha DavisLauren MilnerMaria GarzaL Taylor DavisDann MartinLori C Jordanothers
  • The effect of diagnostic hypercapnic cerebrovascular reactivity imaging on vital signs and acute and follow-up ischemic adverse events in patients with flow-limiting intracranial arterial stenosis

    Journal ArticlePublisher:American Journal of NeuroradiologyDate:2025
    Authors:
    Melanie LeguizamonCaleb HanMaria GarzaMackenzie HorneWesley T RichersonL Taylor DavisDann MartinMatthew FuscoRohan ChitaleLori C Jordanothers
  • Presenting cerebrovascular reactivity as a determinant of direct and indirect surgical revascularization success in North American patients with moyamoya vasculopathy

    Journal ArticlePublisher:Journal of neurosurgeryDate:2025
    Authors:
    Shuhei ShiinoCaleb HanMaria GarzaMatthew FuscoRohan ChitaleL Taylor DavisWesley RichersonMark RodeghierAbigail R DuboisMelanie Leguizamonothers
  • Cerebral vascular shunting and oxygen metabolism in sickle cell disease

    Journal ArticlePublisher:Blood advancesDate:2025
    Authors:
    Alexander K SongWesley T RichersonMegan A AumannSpencer L WaddleR Sky JonesSamantha DavisLauren MilnerChelsea CusterL Taylor DavisSumit Pruthiothers
  • Cerebrovascular reactivity and response times describe recent ischaemic symptomatology in patients with moyamoya

    Journal ArticlePublisher:Brain communicationsDate:2025
    Authors:
    Caleb HanWesley T RichersonMaria GarzaMark RodeghierMurli MishraL Taylor DavisMatthew FuscoRohan ChitaleShuhei ShiinoLori C Jordanothers
  • Choroid plexus vascular reactivity in moyamoya: Implications for choroid plexus regulation in ischemic stress

    Journal ArticlePublisher:Journal of NeuroimagingDate:2024
    Authors:
    Caleb HanSpencer WaddleMaria GarzaLarry T DavisJarrod J EismaWesley T RichersonMatthew FuscoRohan ChitaleChelsea CusterColin D McKnightothers
  • Cerebral hemodynamic changes after haploidentical hematopoietic stem cell transplant in adults with sickle cell disease

    Journal ArticlePublisher:Blood advancesDate:2024
    Authors:
    Megan A AumannWesley RichersonAlexander K SongL Taylor DavisSumit PruthiSamantha DavisNiral J PatelChelsea CusterAdetola A KassimMichael R DeBaunothers

Contact

Address

wesley.richerson@vumc.org